{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:13:31Z","timestamp":1762956811910,"version":"build-2065373602"},"reference-count":75,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Research has been focusing on identifying novel biomarkers to better stratify non-Hodgkin lymphoma patients based on prognosis. Studies have demonstrated that lncRNAs act as miRNA sponges, creating ceRNA networks to regulate mRNA expression, and its deregulation is associated with lymphoma development. This study aimed to identify novel circulating prognostic biomarkers based on miRNA\/lncRNA-associated ceRNA network for NHL. Herein, bioinformatic analysis was performed to construct ceRNA networks for hsa-miR-150-5p and hsa-miR335-5p. Then, the prognostic value of the miRNA\u2013lncRNA pairs\u2019 plasma levels was assessed in a cohort of 113 NHL patients. Bioinformatic analysis identified MALAT1 and NEAT1 as hsa-miR-150-5p and has-miR-335-5p sponges, respectively. Plasma hsa-miR-150-5p\/MALAT1 and hsa-miR335-5p\/NEAT1 levels were significantly associated with more aggressive and advanced disease. The overall survival and progression-free survival analysis indicated that hsa-miR-150-5p\/MALAT1 and hsa-miR335-5p\/NEAT1 pairs\u2019 plasma levels were remarkably associated with NHL patients\u2019 prognosis, being independent prognostic factors in a multivariate Cox analysis. Low levels of hsa-miR-150-5p and hsa-miR-335-5p combined with high levels of the respective lncRNA pair were associated with poor prognosis of NHL patients. Overall, the analysis of ceRNA network expression levels may be a useful prognostic biomarker for NHL patients and could identify patients who could benefit from more intensive treatments.<\/jats:p>","DOI":"10.3390\/ijms23010201","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T01:00:54Z","timestamp":1640566854000},"page":"201","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["ceRNA Network of lncRNA\/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-1109","authenticated-orcid":false,"given":"Mara","family":"Fernandes","sequence":"first","affiliation":[{"name":"Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)\/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)\/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal"},{"name":"Research Department of the Portuguese League against Cancer Regional Nucleus of the North (LPCC-NRN), 4200-177 Porto, Portugal"},{"name":"Faculty of Medicine, University of Porto (FMUP), 4200-319 Porto, Portugal"}]},{"given":"Herlander","family":"Marques","sequence":"additional","affiliation":[{"name":"Life and Health Sciences Research Institute (ICVS), School of Medicine, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal"},{"name":"ICVS\/3B\u2019s\u2014PT Government Associate Laboratory, 4805-017 Braga\/Guimar\u00e3es, Portugal"},{"name":"Department of Oncology, Hospital de Braga, 4710-243 Braga, Portugal"},{"name":"CINTESIS, Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7489-2211","authenticated-orcid":false,"given":"Ana Lu\u00edsa","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)\/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)\/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal"},{"name":"ICBAS\u2014Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, Universidade do Porto, 4050-513 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-8373","authenticated-orcid":false,"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)\/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)\/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal"},{"name":"Research Department of the Portuguese League against Cancer Regional Nucleus of the North (LPCC-NRN), 4200-177 Porto, Portugal"},{"name":"Faculty of Medicine, University of Porto (FMUP), 4200-319 Porto, Portugal"},{"name":"ICBAS\u2014Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, Universidade do Porto, 4050-513 Porto, Portugal"},{"name":"Biomedical Research Center (CEBIMED), Faculty of Health Sciences of Fernando Pessoa University (UFP), 4249-004 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Klener, P., and Klanova, M. (2020). Drug Resistance in Non-Hodgkin Lymphomas. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062081"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00277-014-2271-1","article-title":"Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy","volume":"94","author":"Rovira","year":"2015","journal-title":"Ann. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","article-title":"Outcomes in refractory diffuse large B-cell lymphoma: Results from the international SCHOLAR-1 study","volume":"130","author":"Crump","year":"2017","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"103247","DOI":"10.1016\/j.critrevonc.2021.103247","article-title":"Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma","volume":"159","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Larrabeiti-Etxebarria, A., Lopez-Santillan, M., Santos-Zorrozua, B., Lopez-Lopez, E., and Garcia-Orad, A. (2019). Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma. Cancers, 11.","DOI":"10.3390\/cancers11020144"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"172976","DOI":"10.1016\/j.ejphar.2020.172976","article-title":"Expression of non-coding RNAs in hematological malignancies","volume":"875","author":"Esmaeili","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2019.01.003","article-title":"The circulating transcriptome as a source of cancer liquid biopsy biomarkers","volume":"58","author":"Sole","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s12185-014-1535-9","article-title":"Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma\/leukemias","volume":"99","author":"Ikeda","year":"2014","journal-title":"Int. J. Hematol."},{"key":"ref_13","first-page":"1177271918806840","article-title":"MicroRNAs as Biomarkers of B-cell Lymphoma","volume":"13","author":"Arnaiz","year":"2018","journal-title":"Biomark. Insights"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Karstensen, K.T., Schein, A., Petri, A., B\u00f8gsted, M., Dybk\u00e6r, K., Uchida, S., and Kauppinen, S. (2021). Long Non-Coding RNAs in Diffuse Large B-Cell Lymphoma. Non-Coding RNA, 7.","DOI":"10.3390\/ncrna7010001"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional Classification and Experimental Dissection of Long Noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/carcin\/bgab013","article-title":"LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p\/CBX3 axis in diffuse large B-cell lymphoma","volume":"42","author":"Huang","year":"2021","journal-title":"Carcinogenesis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"650287","DOI":"10.3389\/fonc.2021.650287","article-title":"LncRNA SNHG8 Promotes Proliferation and Inhibits Apoptosis of Diffuse Large B-Cell Lymphoma via Sponging miR-335-5p","volume":"11","author":"Yu","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1010428317701648","DOI":"10.1177\/1010428317701648","article-title":"Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer\/T-cell lymphoma and establishes MIR155HG as a target of PRDM1","volume":"39","author":"Baytak","year":"2017","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/dna.2016.3533","article-title":"lncRNA UCA1 Contributes to Imatinib Resistance by Acting as a ceRNA Against miR-16 in Chronic Myeloid Leukemia Cells","volume":"36","author":"Xiao","year":"2017","journal-title":"DNA Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","article-title":"MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb","volume":"131","author":"Xiao","year":"2007","journal-title":"Cell"},{"key":"ref_23","first-page":"3487","article-title":"miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma","volume":"19","author":"Wang","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1007\/s13277-014-2917-6","article-title":"MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met","volume":"36","author":"Gao","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cas.13452","article-title":"miR-335 inhibited cell proliferation of lung cancer cells by target Tra2\u03b2","volume":"109","author":"Liu","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s12032-014-0982-8","article-title":"MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2","volume":"31","author":"Sun","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1002\/cam4.1682","article-title":"MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2","volume":"7","author":"Liu","year":"2018","journal-title":"Cancer Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3892\/or.2013.2482","article-title":"miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w","volume":"30","author":"Cao","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1158\/1078-0432.CCR-17-1144","article-title":"Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW","volume":"23","author":"Adams","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lungcan.2014.05.011","article-title":"Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes","volume":"85","author":"Yang","year":"2014","journal-title":"Lung Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.molonc.2014.05.010","article-title":"Long noncoding RNA profiles identify five distinct molecular subtypes of colorectal cancer with clinical relevance","volume":"8","author":"Chen","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.18632\/oncotarget.2454","article-title":"Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes","volume":"5","author":"Su","year":"2014","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ma, X.-Y., Wang, J.-H., Wang, J.-L., Ma, C.X., Wang, X.-C., and Liu, F.-S. (2015). Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells. BMC Genom., 16.","DOI":"10.1186\/s12864-015-1881-x"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1073\/pnas.1120791109","article-title":"Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes","volume":"109","author":"Kato","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-016-1100-9","article-title":"LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2","volume":"14","author":"Wang","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/leu.2013.288","article-title":"EZH2 in normal and malignant hematopoiesis","volume":"28","author":"Lund","year":"2014","journal-title":"Leukemia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1182\/blood-2018-06-855502","article-title":"miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels","volume":"132","author":"Musilova","year":"2018","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/16078454.2020.1867781","article-title":"Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia","volume":"26","author":"Sheng","year":"2021","journal-title":"Hematology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"111389","DOI":"10.1016\/j.biopha.2021.111389","article-title":"The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression","volume":"137","author":"Su","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13578-019-0302-2","article-title":"LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p\/AKT3 axis","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"742789","DOI":"10.3389\/fonc.2021.742789","article-title":"LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p\/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses","volume":"11","author":"Vimalraj","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.gene.2018.04.065","article-title":"MYB\u2014A regulatory factor in hematopoiesis","volume":"665","author":"Wang","year":"2018","journal-title":"Gene"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Quintana, A.M., Liu, F., O\u2019Rourke, J.P., and Ness, S.A. (2011). Identification and regulation of c-Myb target genes in MCF-7 cells. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-30"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1073\/pnas.94.7.3296","article-title":"Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity","volume":"94","author":"Salomoni","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bbagrm.2012.03.008","article-title":"Binding of FoxM1 to G2\/M gene promoters is dependent upon B-Myb","volume":"1819","author":"Down","year":"2012","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1128\/MCB.01100-06","article-title":"c-Myb contributes to G2\/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression","volume":"27","author":"Nakata","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0021-9258(18)53990-9","article-title":"c-myb transactivates cdc2 expression via Myb binding sites in the 5\u2032-flanking region of the human cdc2 gene","volume":"268","author":"Ku","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"41544","DOI":"10.1038\/srep41544","article-title":"Discovery of Cancer driver long noncoding RNAs across 1112 tumour genomes: New candidates and distinguishing features","volume":"7","author":"Mularoni","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/1061186X.2019.1585437","article-title":"NEAT1 mediates paclitaxel-resistance of non-small cell of lung cancer through activation of Akt\/mTOR signalling pathway","volume":"27","author":"Li","year":"2019","journal-title":"J. Drug Target."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e12526","DOI":"10.1111\/cpr.12526","article-title":"LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p","volume":"52","author":"Yu","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.2147\/OTT.S220306","article-title":"Long Non-Coding RNA-NEAT1 Promotes Cell Migration and Invasion via Regulating miR-124\/NF-\u03baB Pathway in Cervical Cancer","volume":"13","author":"Shen","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1002\/jcb.26691","article-title":"Long noncoding RNA NEAT1-modulated miR-506 regulates gastric cancer development through targeting STAT3","volume":"120","author":"Tan","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41419-019-1513-5","article-title":"Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness","volume":"10","author":"Shin","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41375-019-0542-5","article-title":"Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma","volume":"34","author":"Taiana","year":"2020","journal-title":"Leukemia"},{"key":"ref_55","first-page":"2135","article-title":"A Novel Mechanism of the c-Myc\/NEAT1 Axis Mediating Colorectal Cancer Cell Response to Photodynamic Therapy Treatment","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41419-020-03164-8","article-title":"LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness","volume":"11","author":"Zhu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3349\/ymj.2019.60.4.336","article-title":"The long noncoding RNA NEAT1 targets miR-34a-5p and drives nasopharyngeal carcinoma progression via Wnt\/\u03b2-catenin signaling","volume":"60","author":"Ji","year":"2019","journal-title":"Yonsei Med. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.2147\/OTT.S142446","article-title":"NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p\/BCL2","volume":"10","author":"Ding","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1002\/jcp.26470","article-title":"NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1","volume":"233","author":"Jiang","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"18985","DOI":"10.1002\/jcp.28538","article-title":"Involvement of NEAT1\/miR-133a axis in promoting cervical cancer progression via targeting SOX4","volume":"234","author":"Yuan","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"173752","DOI":"10.1016\/j.ejphar.2020.173752","article-title":"Lnc NEAT1\/miR-29b-3p\/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells","volume":"891","author":"Che","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40164-020-00187-x","article-title":"Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia","volume":"9","author":"Zheng","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molimm.2019.10.026","article-title":"LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma","volume":"117","author":"Gao","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.biopha.2018.07.046","article-title":"miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells","volume":"106","author":"Luo","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12931-019-1184-x","article-title":"miR-335-5p inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition in non-small cell lung cancer via ROCK1","volume":"20","author":"Du","year":"2019","journal-title":"Respir. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-018-0837-6","article-title":"Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_67","first-page":"1128","article-title":"MiR-335-5p inhibits cell proliferation, migration and invasion in colorectal cancer through downregulating LDHB","volume":"24","author":"Zhang","year":"2019","journal-title":"J. Buon"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/cas.13201","article-title":"Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells","volume":"108","author":"Wang","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1002\/jcp.27484","article-title":"LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p","volume":"234","author":"Liang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/OTT.S191740","article-title":"lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4","volume":"12","author":"Yang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_71","first-page":"150","article-title":"Long non-coding RNA NEAT1 regulates the proliferation, migration and invasion of gastric cancer cells via targeting miR-335-5p\/ROCK1 axis","volume":"73","author":"Wang","year":"2018","journal-title":"Die Pharm. Int. J. Pharm. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"14999","DOI":"10.1002\/jcp.27567","article-title":"Long noncoding RNA NEAT1 suppresses sorafenib sensitivity of hepatocellular carcinoma cells via regulating miR-335\u2013c-Met","volume":"234","author":"Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_74","first-page":"D148","article-title":"miRTarBase 2020: Updates to the experimentally validated microRNA-target interaction database","volume":"48","author":"Huang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:53:14Z","timestamp":1760169194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23010201"],"URL":"https:\/\/doi.org\/10.3390\/ijms23010201","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2021,12,24]]}}}